Related by context. All words. (Click for frequent words.) 80 nonfatal myocardial infarction 80 myocardial infarction stroke 80 nonfatal stroke 79 reinfarction 77 symptomatic VTE 77 HF hospitalization 76 ipsilateral stroke 75 myocardial infarction MI 74 cerebrovascular events 74 composite endpoint 74 periprocedural 73 arterial thromboembolic events 73 CVD mortality 73 cardiovascular hospitalizations 73 cardiovascular hospitalization 73 recurrent venous thromboembolism 72 recurrent ischemia 72 MACCE 72 nondiabetic patients 72 thromboembolic 71 eplerenone 71 cardiovascular mortality 71 nonfatal myocardial infarction MI 71 repeat revascularization 71 TEAEs 71 recurrent VTE 71 nonsignificant 71 systemic embolism 71 refractory ischemia 70 definite stent thrombosis 70 confidence interval #.#-#.# 70 binary restenosis 70 recurrent DVT 70 thromboembolic events 70 intima media thickness 70 myocardial infarctions 69 advanced adenoma 69 ATACAND 69 postoperative mortality 69 thromboembolic complications 69 macrovascular events 69 secondary efficacy endpoint 69 confidence interval CI 69 colorectal adenoma 69 Erythropoietic therapies may 69 myocardial infarction 69 coronary revascularization 69 multivariate adjustment 69 events MACE 69 resuscitated cardiac arrest 69 LVSD 69 CHD CVD 69 postoperative complication 68 univariate analysis 68 carotid stenosis 68 MMSE score 68 β blockers 68 tirofiban 68 % CI #.#-#.# [006] 68 cerebral infarction 68 mL/min/#.# m 2 68 severe exacerbations 68 ischemia driven 68 lowest tertile 68 rebleeding 68 thyrotropin levels 68 adjunctive placebo 68 biochemical recurrence 68 glycated hemoglobin levels 68 nonvertebral fractures 68 thromboembolism 68 periprocedural MI 67 P = .# 67 % CI #.#-#.# [002] 67 fatal myocardial infarction 67 recurrent myocardial infarction 67 locoregional recurrence 67 postintervention 67 proximal DVT 67 postoperative AF 67 thrombotic events 67 androgen suppression 67 left ventricular dysfunction 67 HbA 1c levels 67 multivariate Cox 67 macrovascular 67 microalbuminuria 67 cerebrovascular accident 67 NIHSS score 67 extrapyramidal symptoms 67 morphometric vertebral fractures 67 elevated ALT 67 PSADT 67 Crohn Disease Activity 66 beta blocker therapy 66 hip BMD 66 hemorrhagic complications 66 CR nPR 66 noncardiac 66 VT VF 66 vertebral fracture 66 % Confidence Interval 66 #.#/#.# mmHg [001] 66 Operative mortality 66 noncardiovascular 66 NNT = 66 subclinical hypothyroidism 66 perioperative mortality 66 ischemic cardiomyopathy 66 Myocardial infarction 66 revascularizations 66 mg BID dose 66 upper gastrointestinal bleeding 66 oxycodone CR 66 renal dysfunction 66 death reinfarction 66 Stent thrombosis 66 tertile 66 unstable angina pectoris 66 Postoperative complications 66 p = #.# [003] 66 neurologic complications 66 LV dysfunction 66 MADRS score 66 p = NS 66 HbA1c levels 66 postoperative complications 66 CI #.#-#.# [002] 66 tHcy 66 infarct size 66 % CI #.#-#.# [007] 66 hypoglycemic events 66 de ath 66 univariate analyzes 65 pCR 65 cardiac dysfunction 65 polyp recurrence 65 LOVENOX 65 Kaplan Meier analysis 65 coronary stenosis 65 sustained ventricular tachycardia 65 PRADAXA #mg 65 salmeterol HFA MDI 65 Index CDAI 65 LVEF 65 rosuvastatin #mg 65 NSTEMI 65 distant metastasis 65 multivariable analysis 65 NATRECOR ® 65 hematologic toxicity 65 hypoxemia 65 serum estradiol 65 angiographic restenosis 65 HbA 1c 65 NMIBC 65 TT genotype 65 x ULN 65 endometrial hyperplasia 65 carotid intima media 65 XIENCE V demonstrated 65 CHD mortality 65 carotid IMT 65 ARCOXIA 65 left ventricular systolic 65 TAXUS p value 65 cardiovascular morbidity 65 tertiles 65 prolonged QT interval 65 myocardial ischemia 65 target vessel revascularization 65 androgen deprivation 65 irbesartan 65 p = .# [002] 65 perioperative complications 65 QTc prolongation 65 symptomatic intracranial 64 neurodevelopmental impairment 64 nonfatal cardiovascular 64 alanine aminotransferase 64 severe neutropenia 64 syncopal 64 histologic subtype 64 cilostazol 64 biochemical relapse 64 hypoglycemic episodes 64 creatinine ratio 64 advanced adenomas 64 ALT elevation 64 univariate 64 baseline HbA1c 64 serum creatinine levels 64 laboratory abnormalities 64 CI #.#-#.# [001] 64 postoperative morbidity 64 Folfox 64 nonischemic 64 paroxysmal AF 64 subtrochanteric 64 COPD exacerbation 64 malignant neoplasm 64 systolic dysfunction 64 carotid artery blockage 64 noncardiovascular mortality 64 gastrointestinal perforation 64 microvascular complications 64 CCyR 64 XIENCE V PROMUS Stent 64 hormone receptor negative 64 postoperative chemotherapy 64 NYHA Class II 64 plasma cortisol 64 hsCRP levels 64 revascularization procedures 64 prospectively defined 64 endometrial carcinoma 64 CI -#.# 64 nonfasting triglyceride levels 64 nonsignificant difference 64 stroke myocardial infarction 64 prespecified 64 generalized edema 64 rehospitalization 64 nonvertebral fracture 64 Hb A1C 64 myocardial fibrosis 64 ischemic cardiovascular 64 nodal metastases 64 p = .# [001] 64 flutamide 64 pericardial effusion 64 HOMA IR 64 ximelagatran 64 ECG abnormalities 64 fibrinolysis 64 dysglycemia 64 #q# deletion syndrome 64 colorectal adenomas 64 hypoperfusion 64 preoperative PSA 64 acute myocardial infarctions 64 SCr 64 SUVmax 64 Prehypertension 64 atherothrombotic disease 64 highest tertile 64 serum uric acid 64 patients undergoing CABG 64 PREZISTA r arm 64 macroalbuminuria 64 serum testosterone 64 perioperatively 64 atheroma volume 64 HbA1C levels 64 ventricular tachyarrhythmia 64 CDAI score 64 eptifibatide 64 MetS 64 paclitaxel eluting stents 64 % CI #.#-#.# [003] 64 nonfasting triglycerides 64 pyrexia mucositis sepsis febrile 64 Adjuvant chemotherapy 64 elevated IOP 64 prostate cancer CaP 64 ziprasidone 64 non valvular atrial 63 virologic failure 63 leucopenia 63 nadroparin 63 ertapenem 63 hyperkalemia 63 logistic regression model 63 adenoma 63 candesartan 63 treatment emergent adverse 63 QRS duration 63 renal insufficiency 63 preintervention 63 interquartile range 63 lopinavir r arm 63 % CI #.#-#.# [008] 63 intracerebral haemorrhage 63 prespecified secondary 63 NATRECOR R 63 NYHA functional class 63 % CI #.#-#.# [004] 63 nonfatal pulmonary embolism 63 unfractionated heparin UFH 63 covariate 63 multivariable adjusted 63 chlorambucil 63 asymptomatic carotid stenosis 63 unfractionated heparin 63 adrenal insufficiency 63 thyrotoxicosis 63 highest quintile 63 atherothrombotic 63 PLX STROKE targeting 63 confidence intervals CIs 63 hepatotoxicity 63 atherogenic dyslipidemia 63 desvenlafaxine succinate 63 subclinical hyperthyroidism 63 β blocker 63 cardioembolic stroke 63 hyperacute 63 autonomic dysfunction 63 PSA nadir 63 ABCB1 63 intracerebral hemorrhage 63 valvular disease 63 transaminase elevations 63 liver histology 63 malignant neoplasms 63 neutropenia dehydration dyspnea 63 mcg QD 63 subclinical atherosclerosis 63 serum aminotransferase levels 63 familial aggregation 63 troponin T 63 contrast induced nephropathy 63 aneurysmal subarachnoid hemorrhage 63 pulmonary embolism PE 63 thromboses 63 symptomatic atrial fibrillation 63 TAXUS Express Stent 63 EXJADE 63 fractional shortening 63 Ishak fibrosis score 63 adjunctive ABILIFY 63 depressive symptomatology 63 ventricular arrhythmia 63 5-FU/LV 63 EBRT 63 Torsades de Pointes 63 angiotensin converting enzyme inhibitors 63 comorbid conditions 63 PASI scores 63 TRITON TIMI 63 parous women 63 severe hypoglycemia 63 STRIDE PD 63 hypokalemia 63 Arch Intern Med 63 systolic hypertension 63 QTc 63 ALT flares 63 histologically confirmed 63 abciximab 63 aminotransferases 63 pulmonary dysfunction 63 haemorrhagic stroke 63 Subgroup analysis 63 neutrophil counts 63 glycated hemoglobin HbA1c 63 hypophosphatemia 63 EDSS scores 63 cryptogenic 63 glomerular filtration rate 63 lipid lowering agents 63 thrombotic complications 63 serum urate levels 63 platelet reactivity 63 RE LY ® 63 carotid atherosclerosis 63 serum triglycerides 63 ARB telmisartan 63 confirmed thrombotic cardiovascular 63 invasive ductal 63 MIs 63 Hypotension 63 enalapril 63 sotalol 62 atrophic gastritis 62 hepatic cirrhosis 62 certolizumab 62 Primary endpoints 62 cerebral vasospasm 62 diastolic blood pressures 62 aldosterone antagonist 62 NIH CPSI 62 UACR 62 estimated glomerular filtration 62 lumbar spine BMD 62 events TEAEs 62 HBeAg negative patients 62 symptomatic intracranial hemorrhage 62 elevated LDH 62 hyperalgesia 62 serum phosphate 62 torsade de pointes 62 prednisone prednisolone 62 glycosylated hemoglobin HbA1c 62 bronchopulmonary dysplasia 62 Infusion Reactions Severe 62 hypercalcemia 62 coronary artery calcification 62 hippocampal atrophy 62 systemic corticosteroid 62 HDRS 62 neonatal morbidity 62 graft dysfunction 62 serum calcium levels 62 concomitant medications 62 postdischarge 62 hyperhomocysteinemia 62 cerebrovascular accidents 62 NHANES III 62 anastomotic leak 62 inhospital 62 psychiatric comorbidities 62 liver transplant recipients 62 Doxil ® 62 REYATAZ r arm 62 mcg BID 62 hyperglycaemia 62 pretest probability 62 venous thrombosis 62 intravenous bisphosphonates 62 recurrent atrial fibrillation 62 intracerebral hemorrhages 62 BYSTOLIC 62 endometrial thickness 62 % CI #.#-#.# [001] 62 venous thromboembolic events 62 discontinuations due 62 cytopenias 62 Events MACE 62 comorbidity 62 D dimer 62 NNRTI resistance 62 acute myocardial infarction AMI 62 Thal Dex 62 nephrotoxicity 62 overt hepatic encephalopathy HE 62 intraoperative complications 62 salmeterol fluticasone 62 posttransplant 62 LV ejection fraction 62 atrioventricular block 62 TNF antagonist 62 tiotropium 62 pericardial effusions 62 nonadherence 62 ischemic lesions 62 asthma exacerbations 62 Montgomery Åsberg Depression 62 chlorthalidone 62 aspartate aminotransferase AST 62 graft occlusion 62 vasospasm 62 rs# [002] 62 alteplase 62 meta regression 62 preoperative chemotherapy 62 severe hypoglycemic 62 tolvaptan 62 VADT 62 QIDS SR 62 Subgroup analyzes 62 olmesartan 62 artery reclogging 62 statistically nonsignificant 62 macrovascular disease 62 hematuria 62 tibolone 62 preserved ejection fraction 62 systolic BP 62 nonobese 62 pyelonephritis 62 Y BOCS 62 annualized relapse 62 FluCAM arm 62 hepatorenal syndrome 62 angiotensin converting enzyme inhibitor 62 clinicopathological features 62 serum homocysteine 62 ejection fractions 62 nondiabetics 62 clinically meaningful reductions 62 aspartate aminotransferase 62 echocardiographic parameters 62 intensive statin therapy 62 microvascular disease 62 tapentadol ER 62 Thrombolysis 62 intraventricular hemorrhage 62 serum parathyroid hormone 62 QTc intervals 62 SLNB 62 Taxus Stent 62 adenoma recurrence 62 CTEPH 62 deep venous thromboses 62 lipid lowering therapy 62 generalized seizures 62 mg kg dose 62 mycophenolate mofetil 62 abacavir lamivudine 62 MMSE scores 62 Renal dysfunction 62 lipid lowering drugs 62 Venous thromboembolism 62 spinal cord compression 62 advanced neoplasia 62 apnea hypopnea 62 fasting insulin 62 endarterectomy 62 logistic regression analysis 62 lacunar 62 Complication rates 62 nadolol 62 microbleeds 62 liver metastasis 62 ventricular dysfunction 62 symptomatic pulmonary embolism 62 Serious adverse reactions 62 adnexal mass 62 oral allopurinol 62 haemorrhagic strokes 62 TMP SMX 62 retrograde ejaculation 62 statistical significance p 62 T2DM 62 TAVR 62 timepoints 62 plasma homocysteine 62 #mmHg [001] 62 familial AF 61 receiving VICTRELIS 61 alanine aminotransferase ALT 61 TNF blocker therapy 61 CC genotype 61 invasive carcinomas 61 liver decompensation 61 intraobserver 61 apolipoprotein B 61 coronary revascularisation 61 venous thromboembolisms 61 haematologic 61 serum urate 61 ischemic stroke 61 postop 61 PCa 61 posttreatment 61 gestational hypertension 61 stent thromboses 61 serum BDNF 61 valsartan 61 MDRD 61 lispro 61 posaconazole 61 serum IGF 61 undergoing CABG 61 fatal IHD 61 everolimus eluting stents 61 Index CDAI score 61 Hazard Ratio 61 colorectal neoplasia 61 febrile neutropenia 61 VIIBRYD 61 rFVIIa 61 artery stenosis 61 peri procedural 61 oral diclofenac 61 VTE 61 stroke transient ischemic 61 mcg albinterferon alfa 2b 61 multivariate analyzes 61 HBeAg seroconversion 61 metabolic acidosis 61 underwent CABG 61 ezetimibe simvastatin 61 TAXUS Liberte Long 61 clinically insignificant 61 baseline serum creatinine 61 ticagrelor 61 venous thromboembolic disease 61 KIF6 carriers 61 POAG 61 onset diabetes mellitus 61 covariates 61 nicardipine 61 pelvic lymphadenectomy 61 BRCA1 mutation carriers 61 apnea hypopnea index 61 protein excretion 61 bivalirudin 61 prasugrel uh prevented 61 HIV HCV coinfected 61 CK MB 61 CR CRu 61 Kaplan Meier estimates 61 coinfected patients 61 dyslipidaemia 61 Baseline characteristics 61 achieved ACR# 61 infarctions 61 variant angina 61 p = 61 white matter hyperintensities 61 bezafibrate 61 myocardial reperfusion 61 pamidronate 61 arterial occlusion 61 thyrotropin 61 arterial thickening 61 Febrile neutropenia 61 urine albumin 61 eGFR 61 spontaneous bacterial peritonitis 61 #mg/day [001] 61 NIHSS 61 nmol l 61 HAM D# scores 61 nocturnal hypoglycemia 61 gallstone disease 61 asymptomatic PAD 61 idraparinux 61 pegylated liposomal doxorubicin 61 Montgomery Asberg Depression 61 headache nasopharyngitis 61 hypercalciuria 61 platelet activation 61 acute cholecystitis 61 myocardial infarctions MIs 61 DES implantation 61 adenomatous polyps 61 tumor lysis syndrome 61 femoral neck BMD 61 postoperative delirium 61 chemoradiotherapy 61 recurrent glioblastoma multiforme 61 placebo dexamethasone 61 pneumonectomy 61 undergone radical prostatectomy 61 fatal pulmonary embolism 61 elevated triglyceride levels 61 odds ratios ORs 61 onset atrial fibrillation 61 oral hypoglycemic agents 61 virologic response 61 dyssynchrony 61 ARIXTRA 61 albuminuria 61 hemoglobin A1c HbA1c 61 sd = 61 hepatectomy 61 intact parathyroid hormone 61 comorbidities 61 μmol L 61 HGPIN 61 GP IIb IIIa inhibitors 61 angiographic outcomes 61 antithrombotic therapies 61 Rating Scale MADRS 61 GnRH agonists 61 aspirin clopidogrel 61 serum PSA 61 diastolic hypertension 61 nonfatal myocardial infarctions 61 pT3 61 hypercholesterolaemia 61 lymphopenia 61 lactic acidosis 61 curative resection 61 hemodynamically significant 61 rCBF 61 Ischemic stroke 61 CDAI 61 multivariable Cox 61 aminotransferase levels 61 dysmenorrhoea 61 radical nephrectomy 61 artery occlusion 61 hypomagnesemia 61 cTnT 61 p = #.# [002] 61 angina pectoris 61 nonoperative treatment 61 thrombocytopenic 61 thromboprophylaxis 61 platelet inhibition 61 malperfusion 61 Severe hypoglycemia 61 cryptogenic stroke 61 Kaplan Meier curve 61 postoperative atrial fibrillation 61 systemic corticosteroids 61 proximal colon 61 cTnT levels 61 ≥ 61 squamous histology 61 benazepril 61 paresthesias 61 dalteparin 61 A1c levels 61 Hazard Ratio HR 61 beta carotene supplementation 61 hemorrhagic strokes 61 symptomatic intracerebral hemorrhage 61 coronary artery stenosis 61 nontraumatic 61 axillary node 61 receiving INTRON 61 insulin detemir 61 contralateral breast cancer 61 #.#ng/ml 61 ALT elevations 61 pioglitazone 61 IIIa inhibitor 61 Secondary endpoints included 61 serum sodium 61 Brief Psychiatric 61 incidence ≥ 61 sirolimus stent 61 syndromal 61 serum HCV RNA 61 HRQoL 61 neurologic progression 61 diastolic BP 61 #mg BID [003] 61 lymphadenectomy 61 GP IIb IIIa inhibitor 61 clodronate 61 NYHA class 61 atrioventricular valve 61 euthyroid 61 K ras mutations 61 stage IIIb IV 61 coronary revascularization procedures 61 venous thrombotic events 61 perioperative morbidity 61 IRLS score 61 endoscopic remission 61 HMG CoA reductase inhibitors 61 BENICAR HCT 61 progesterone receptor negative 61 H. pylori eradication 61 noncarriers 61 SSc 61 coagulopathy 61 cytogenetic response 61 elevated serum creatinine 61 QTcF 60 umol L 60 VTEs 60 F FDG PET 60 undergoing coronary angiography 60 revascularization 60 HSCT 60 APACHE II 60 adverse perinatal 60 CHADS2 60 tipranavir r 60 neurologic symptoms 60 overt nephropathy 60 moderate renal impairment 60 Diabetic nephropathy 60 ventricular fibrillation VF 60 lipid lowering medications 60 thiazide diuretics 60 tamsulosin 60 response pCR 60 PAOD 60 prostate cancer PCa 60 CIMZIA TM certolizumab pegol 60 quetiapine risperidone 60 serum creatinine 60 perinatal complications 60 elevated LDL cholesterol 60 -#.# ± [002] 60 interstitial pneumonia 60 transurethral resection 60 pancreatectomy 60 achieved statistical significance 60 prolactin levels 60 fulminant hepatic failure 60 Visual Analogue Scale VAS 60 nonresponders 60 KRAS mutations occur 60 sonographic findings 60 proteinuria 60 serum calcium 60 residual confounding 60 APTIVUS r 60 acute coronary 60 indapamide 60 Nesiritide 60 reintervention 60 glomerular filtration 60 ng dL 60 sensory neuropathy 60 micafungin 60 underwent resection 60 adriamycin 60 cardiogenic shock 60 abdominal adiposity 60 recurrent wheezing 60 nonselective NSAIDs 60 BMI z 60 rosuvastatin 60 homocysteine concentrations 60 FOLFIRI 60 GnRH agonist 60 left ventricular hypertrophy 60 typical antipsychotics 60 placebo p = 60 ST elevation myocardial 60 Scale EDSS score 60 Navelbine 60 Hemorrhagic stroke 60 MGUS 60 cytogenetic abnormalities 60 visceral adiposity 60 renal scarring 60 cranial irradiation 60 lymphocytosis 60 comparator arm 60 wound dehiscence 60 sleeve lobectomy 60 adrenal suppression 60 lamivudine monotherapy 60 NSTE ACS 60 pulmonary exacerbations 60 left ventricular LV 60 decompensated heart failure 60 steatosis 60 HBeAg 60 cisplatin vinorelbine 60 postprocedure 60 Carotid Revascularization Endarterectomy vs. 60 leukopenia 60 pretransplant 60 tumor recurrence 60 divalproex sodium 60 microvessel density 60 hemodilution 60 undergoing coronary artery 60 urolithiasis 60 Ejection Fraction 60 iodixanol 60 otamixaban 60 antiphospholipid antibodies 60 fasting glucose levels 60 amenorrhoea 60 tricuspid regurgitation 60 antiarrhythmic drug 60 skeletal metastases 60 foveal thickness 60 drotrecogin alfa activated 60 ventricular mass 60 angina chest 60 leiomyomas 60 plus dexamethasone 60 N telopeptide 60 metachronous 60 serum leptin 60 variceal bleeding 60 mmHg diastolic 60 postoperative bleeding 60 androgen ablation 60 TAXUS Stent 60 silent ischemia 60 atherosclerotic progression 60 SGRQ 60 invasive aspergillosis 60 fasting triglycerides 60 intracranial stenosis 60 depressive symptom 60 CIMZIA ™ 60 hepatic metastases 60 venous thromboembolism 60 hypertension diabetes mellitus 60 CsA 60 #mg BID [001] 60 dose atorvastatin 60 CYPHER Stent 60 thrombolytic therapy 60 enoxaparin 60 intracerebral hemorrhage ICH 60 Apgar scores 60 fluvastatin 60 coronary stenoses 60 fluticasone salmeterol 60 ischemic complications 60 #ng/ml 60 IOP lowering 60 revascularisation 60 intravitreal injections 60 affective psychosis 60 target lesion revascularization 60 chemoradiation therapy 60 noninferior 60 PRADAXA 60 warfarin therapy 60 aortic regurgitation 60 acute coronary syndromes ACS 60 secondary endpoint 60 QT prolongation 60 exemestane 60 CrCl 60 thrombophlebitis 60 stenoses 60 urgent coronary revascularization 60 sUA 60 glycated hemoglobin 60 antiplatelet drugs 60 HER2 expression 60 NPH insulin 60 induce orthostatic hypotension 60 retrospective cohort 60 argatroban 60 â ‰ ¥ 60 tumor histology 60 pg ml 60 Proteinuria 60 pheochromocytoma 60 zonisamide SR 60 bolus dose 60 salmeterol fluticasone propionate 60 XELOX 60 nondepressed 60 cerebral infarctions 60 CYPHER ® 60 hypopneas 60 virological failure 60 treatment emergent AEs 60 clopidogrel 60 embolic stroke 60 statistically significant p = 60 secondary efficacy endpoints 60 ß blockers 60 IBDQ 60 hydroxymethyl coenzyme 60 hypoglycaemic episodes 60 virologic breakthrough 60 akathisia 60 triglyceride concentrations 60 prognostic variables 60 stable angina 60 autoantibody levels 60 distant metastases 60 ischemic cerebrovascular 60 cytoreductive surgery 60 DLTs 60 acute coronary syndrome 60 ADHF 60 paroxetine Paxil 60 transferrin saturation 60 cerebrovascular disease 60 gadobutrol 60 poor metabolizers 60 conjunctival hyperemia 60 conjugated estrogens 60 gastrointestinal bleeds 60 aldosterone antagonists 60 fondaparinux 60 #OHD 60 carotid artery stenosis 60 sirolimus eluting stents 60 glycoprotein IIb IIIa inhibitors 60 torsades de pointes 60 octreotide LAR 60 hematologic adverse 60 adjuvant radiotherapy 60 cerebral microbleeds 60 Psoriasis Area 60 contralateral breast 60 Mitral regurgitation 60 Radical prostatectomy 60 serum glucose 60 postoperative infections 60 tHcy concentrations 60 intra abdominal abscess 60 corrected QT interval 60 elevated transaminases 60 antiandrogen 60 delayed gastric emptying 60 peripheral sensory neuropathy 60 nonobstructive CAD 60 reoperations 60 DAS# remission 60 Exclusion criteria 60 neutropenic sepsis 60 Restenosis 60 intravesical therapy 60 hepatocellular carcinomas 60 PEGINTRON TM 60 metoprolol tartrate 60 bivariate analyzes 60 hyperintense lesions 60 locoregional 60 progression TTP 60 serum phosphorous 60 nonfatal cardiac arrest 60 hepatic failure 60 underwent surgical resection